Skip to content

H2020HORIZONFP7

Ospedale San Raffaele SRL

Country
ITItaly
Defence projects
0
Projects, all programmes
121
As coordinator
49
EU contribution (CORDIS)
EUR 59,091,116
Active
2008 to 2025

Projects

121 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
NEVAINeurovascular Interactions and Pathfinding in the Spinal Motor SystemFP72015CoordinatorEUR 1,653,000
OPERANDOOnline Privacy Enforcement, Rights Assurance and OptimizationH20202015Third partyNot stated
HSCSFORLSDBRAINHSC-based therapies for LSDs: understanding the modalities of cell replacement in the LSD brain for improving therapeutic efficacyFP72014CoordinatorEUR 1,751,147
REPROPARKNew experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogrammingFP72014CoordinatorEUR 1,995,267
ATTACKAdoptive engineered T cell Trials to Achieve Cancer KillingFP72012ParticipantEUR 266,000
I-SURIntelligent Surgical RoboticsFP72011ParticipantEUR 54,450
PTPN22 IN T1DEffect of PTPN22 on Treg to Teff equilibrium in human and murine autoimmune diabetesFP72011CoordinatorNot stated
SECRETASES & MYELINRole of secretases in myelinationFP72010CoordinatorNot stated
ALIZ-EAdaptive Strategies for Sustainable Long-Term Social InteractionFP72010ParticipantEUR 77,100
TCLOUDSTrustworthy Clouds – Privacy and Resilience for Internet-scale Critical InfrastructureFP72010ParticipantEUR 70,128
TERMLinking research organisations in the fields of Tissue Engineering and Regenerative Medicine through European cooperation between regional research clustersFP72010ParticipantEUR 55,084
IMMEEDIAImmunomodulatory Effects of Exercise in Type 1 DiabetesFP72010ParticipantNot stated
ELLIOTExperiential Living Lab for the Internet Of ThingsFP72010ParticipantEUR 0
SAFROSPatient Safety in Robotic SurgeryFP72010ParticipantEUR 36,392
TARGETINGGENETHERAPYTowards Safe and Effective Hematopoietic Stem Cell Gene Therapy: Targeting Integration to Genomic Safe Harbors and Exploiting Endogenous microRNA to Regulate Transgene ExpressionFP72010ParticipantEUR 1,096,198
LIVER IVM AND HBVImaging liver immunopathology by intravital microscopy (IVM): a new approach to study the pathogenesis of hepatitis B virus (HBV) infectionFP72010CoordinatorEUR 1,298,621
MMSCNovel therapeutic antibodies for multiple myelomaFP72009CoordinatorNot stated
ATTRACTAdvanced Teaching and TRaining for Adoptive Cell TherapyFP72009ParticipantEUR 202,273
LEUKEMIA AND VEGFRole of angiogenesis in leukemiaFP72009CoordinatorNot stated
NGINNext Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodiesFP72008ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.